CircIdh2 Attenuates Endothelial-to-Mesenchymal Transition and Myocardial Fibrosis and Exhibits Translational Potential

IF 2.8 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Yanjia Chen, Xinai Meng, Tian Liu, Yuchen Zhang, Xingfu Huang
{"title":"CircIdh2 Attenuates Endothelial-to-Mesenchymal Transition and Myocardial Fibrosis and Exhibits Translational Potential","authors":"Yanjia Chen,&nbsp;Xinai Meng,&nbsp;Tian Liu,&nbsp;Yuchen Zhang,&nbsp;Xingfu Huang","doi":"10.1155/cdr/2005876","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Background</h3>\n \n <p>Endothelial-to-mesenchymal transition (EndMT) contributes to myocardial fibrosis after cardiac injury. Circular RNAs (circRNAs) have been implicated in the regulation of EndMT, but whether circRNAs participate in this process through translational potential remains unclear. This study investigated the role of circIdh2 in EndMT and examined whether its coding capacity may contribute to its biological effects.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Rat endothelial progenitor cells (rEPCs) were treated with TGF-<i>β</i>1 (5 ng/mL) for 7 days to induce EndMT. The expression of circSorbs1, circIdh2, and circSntb2 was measured by qRT-PCR. EndMT-related markers, including VE-cadherin, vimentin, and N-cadherin, were detected by western blotting. Cell migration was assessed using Transwell and scratch wound healing assays. The translational potential of circIdh2 was examined using an Idh2-IRES luciferase reporter assay, FLAG immunoprecipitation followed by western blotting, and mass spectrometry. A circIdh2 mutant construct and a rat model of acute myocardial infarction (AMI) were used to further evaluate the contribution of circIdh2 and its putative circIdh2-derived product.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>TGF-<i>β</i>1 reduced the expression of circSorbs1, circIdh2, and circSntb2 in rEPCs. CircIdh2 showed the largest decrease in the initial qRT-PCR screen and was selected before any circIdh2-specific functional experiment. The Idh2 host gene supplied metabolic and redox context for the prespecified screen but was not used as evidence of circIdh2 function. CircIdh2 overexpression increased VE-cadherin expression, decreased vimentin and N-cadherin expression, and attenuated TGF-<i>β</i>1–induced cell migration. In contrast, circIdh2 knockdown promoted EndMT-associated marker changes and cell migration. The Idh2-IRES reporter assay, FLAG immunoprecipitation, and mass spectrometry supported the translational potential of circIdh2 and detected a FLAG-tagged product derived from the circIdh2 expression construct. The FLAG-tagged circIdh2 expression construct modulated EndMT-related markers and reduced cell migration, whereas the coding-disrupted mutant construct did not reproduce the effects of wild-type circIdh2. In vivo, AAV-mediated delivery of circIdh2 or circIdh2-aa attenuated myocardial fibrosis and partly reversed EndMT-related marker changes after AMI.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>CircIdh2 attenuated EndMT-associated changes in rEPCs and was associated with reduced myocardial fibrosis after AMI. These findings support the translational potential of circIdh2 and suggest that its putative circIdh2-derived product may contribute to its effects.</p>\n </section>\n </div>","PeriodicalId":9582,"journal":{"name":"Cardiovascular Therapeutics","volume":"2026 1","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/cdr/2005876","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/cdr/2005876","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Endothelial-to-mesenchymal transition (EndMT) contributes to myocardial fibrosis after cardiac injury. Circular RNAs (circRNAs) have been implicated in the regulation of EndMT, but whether circRNAs participate in this process through translational potential remains unclear. This study investigated the role of circIdh2 in EndMT and examined whether its coding capacity may contribute to its biological effects.

Methods

Rat endothelial progenitor cells (rEPCs) were treated with TGF-β1 (5 ng/mL) for 7 days to induce EndMT. The expression of circSorbs1, circIdh2, and circSntb2 was measured by qRT-PCR. EndMT-related markers, including VE-cadherin, vimentin, and N-cadherin, were detected by western blotting. Cell migration was assessed using Transwell and scratch wound healing assays. The translational potential of circIdh2 was examined using an Idh2-IRES luciferase reporter assay, FLAG immunoprecipitation followed by western blotting, and mass spectrometry. A circIdh2 mutant construct and a rat model of acute myocardial infarction (AMI) were used to further evaluate the contribution of circIdh2 and its putative circIdh2-derived product.

Results

TGF-β1 reduced the expression of circSorbs1, circIdh2, and circSntb2 in rEPCs. CircIdh2 showed the largest decrease in the initial qRT-PCR screen and was selected before any circIdh2-specific functional experiment. The Idh2 host gene supplied metabolic and redox context for the prespecified screen but was not used as evidence of circIdh2 function. CircIdh2 overexpression increased VE-cadherin expression, decreased vimentin and N-cadherin expression, and attenuated TGF-β1–induced cell migration. In contrast, circIdh2 knockdown promoted EndMT-associated marker changes and cell migration. The Idh2-IRES reporter assay, FLAG immunoprecipitation, and mass spectrometry supported the translational potential of circIdh2 and detected a FLAG-tagged product derived from the circIdh2 expression construct. The FLAG-tagged circIdh2 expression construct modulated EndMT-related markers and reduced cell migration, whereas the coding-disrupted mutant construct did not reproduce the effects of wild-type circIdh2. In vivo, AAV-mediated delivery of circIdh2 or circIdh2-aa attenuated myocardial fibrosis and partly reversed EndMT-related marker changes after AMI.

Conclusions

CircIdh2 attenuated EndMT-associated changes in rEPCs and was associated with reduced myocardial fibrosis after AMI. These findings support the translational potential of circIdh2 and suggest that its putative circIdh2-derived product may contribute to its effects.

CircIdh2减弱内皮到间质转化和心肌纤维化,并表现出转化潜能。
背景:心脏损伤后,内皮-间质转化(EndMT)有助于心肌纤维化。环状rna (circRNAs)参与了EndMT的调控,但环状rna是否通过翻译潜能参与这一过程尚不清楚。本研究探讨了circIdh2在EndMT中的作用,并探讨了其编码能力是否有助于其生物学效应。方法:用TGF-β1 (5 ng/mL)处理大鼠内皮祖细胞(rEPCs) 7 d诱导EndMT。采用qRT-PCR检测circSorbs1、circsid2和circSntb2的表达。western blotting检测endmt相关标记,包括VE-cadherin、vimentin和N-cadherin。采用Transwell法和抓伤愈合法评估细胞迁移。circIdh2的翻译潜力通过Idh2-IRES荧光素酶报告实验、FLAG免疫沉淀、western blotting和质谱分析来检测。利用circIdh2突变体构建和急性心肌梗死(AMI)大鼠模型进一步评估circIdh2及其衍生产物的作用。结果:TGF-β1降低了rEPCs中circSorbs1、circsid2、circSntb2的表达。CircIdh2在最初的qRT-PCR筛选中下降幅度最大,并且在任何CircIdh2特异性功能实验之前被选中。Idh2宿主基因为预先指定的筛选提供了代谢和氧化还原环境,但没有作为circIdh2功能的证据。CircIdh2过表达增加VE-cadherin表达,降低vimentin和N-cadherin表达,减弱TGF-β1诱导的细胞迁移。相比之下,circIdh2敲低促进了endmt相关标记的变化和细胞迁移。Idh2-IRES报告基因分析、FLAG免疫沉淀和质谱分析支持circIdh2的翻译潜力,并检测到源自circIdh2表达结构的FLAG标记产物。flag标记的circIdh2表达结构调节了endmt相关标记并减少了细胞迁移,而编码中断的突变结构没有再现野生型circIdh2的效果。在体内,aav介导的circIdh2或circIdh2-aa的递送减轻了心肌纤维化,部分逆转了AMI后endmt相关标志物的变化。结论:CircIdh2减轻了endmt相关的rEPCs变化,并与AMI后心肌纤维化减少有关。这些发现支持circIdh2的翻译潜力,并表明其推测的circIdh2衍生产物可能有助于其作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular Therapeutics
Cardiovascular Therapeutics 医学-心血管系统
CiteScore
5.60
自引率
0.00%
发文量
55
审稿时长
6 months
期刊介绍: Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged. Subject areas include (but are by no means limited to): Acute coronary syndrome Arrhythmias Atherosclerosis Basic cardiac electrophysiology Cardiac catheterization Cardiac remodeling Coagulation and thrombosis Diabetic cardiovascular disease Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF) Hyperlipidemia Hypertension Ischemic heart disease Vascular biology Ventricular assist devices Molecular cardio-biology Myocardial regeneration Lipoprotein metabolism Radial artery access Percutaneous coronary intervention Transcatheter aortic and mitral valve replacement.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书